Search Results - "Carrasco, Rosa A."
-
1
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer
Published in The Journal of clinical investigation (15-11-2023)“…Prostate cancer is generally considered an immunologically "cold" tumor type that is insensitive to immunotherapy. Targeting surface antigens on tumors through…”
Get full text
Journal Article -
2
Antisense inhibition of survivin expression as a cancer therapeutic
Published in Molecular cancer therapeutics (01-02-2011)“…Survivin, a family member of the inhibitor of apoptosis proteins that is expressed during mitosis in a cell cycle-dependent manner and localized to different…”
Get full text
Journal Article -
3
A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors
Published in Cancer research (Chicago, Ill.) (15-01-2016)“…Elevated levels of the proinflammatory cytokine IL6 are associated with poor survival outcomes in many cancers. Antibodies targeting IL6 and its receptor have…”
Get full text
Journal Article -
4
One-step cellular caspase-3/7 assay
Published in BioTechniques (01-05-2003)Get full text
Journal Article -
5
A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response
Published in Molecular cancer therapeutics (01-04-2016)“…HER3/ERBB3 is a kinase-deficient member of the EGFR family receptor tyrosine kinases (RTK) that is broadly expressed and activated in human cancers. HER3 is a…”
Get full text
Journal Article -
6
The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of MyoD
Published in The EMBO journal (02-03-1998)“…A good model system to examine aspects of positive and negative transcriptional regulation is the muscle‐specific regulatory factor, MyoD, which is a basic…”
Get full text
Journal Article -
7
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers
Published in Clinical cancer research (08-11-2024)“…Abstract Purpose: Claudin 18.2 (CLDN18.2) is a surface membrane protein that is crucial for maintaining tight junctions in gastric mucosal cells and is highly…”
Get full text
Journal Article -
8
Role of exogenous inositol and phosphatidylinositol in glycosylphosphatidylinositol anchor synthesis of GP49 by Giardia lamblia
Published in Biochimica et biophysica acta (03-01-2000)“…Although Giardia lamblia trophozoites are unable to carry out de novo phospholipid synthesis, they can assemble complex glycophospholipids from simple lipids…”
Get full text
Journal Article -
9
Antitumor activity of AZD0754, a dnTGF[beta]RII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer
Published in The Journal of clinical investigation (15-11-2023)“…Prostate cancer is generally considered an immunologically "cold" tumor type that is insensitive to immunotherapy. Targeting surface antigens on tumors through…”
Get full text
Journal Article -
10
EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer target
Published in Cancer biology & therapy (01-06-2012)“…EphB4 is a member of the Eph receptor tyrosine kinase family shown to act in neuronal guidance and mediate venal/arterial separation. In contrast to these more…”
Get full text
Journal Article -
11
Abstract 2272: Understanding resistance to Trail and Trail agonists
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Abstract Trail and Trail agonists induce apoptotic cell death in cancer cells while sparing normal cells making them promising drug candidates. However, Trail…”
Get full text
Journal Article -
12
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancer
Published in Clinical cancer research (25-09-2024)“…CLDN18.2 is a surface membrane protein crucial for maintaining tight junctions in gastric mucosal cells and is highly expressed in gastric, esophageal, and…”
Get full text
Journal Article -
13
Abstract 558: MEDI3379, a human monoclonal antibody against HER3, suppresses HER3 activity and cell proliferation in both ligand-dependent and independent cancers
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract HER3 (ErbB3) is a member of the EGFR/HER family of receptor tyrosine kinases (RTK), consisting of EGFR, HER2, HER3 and HER4. Due to its unique…”
Get full text
Journal Article -
14
Abstract 239: A novel multimeric protein scaffold stimulates apoptotic signaling through TRAILR2
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract TRAILR2 (DR5, TNFRSF10B) is a member of the TNF-receptor superfamily that mediates programmed cell death following stimulation with its ligand…”
Get full text
Journal Article -
15
Abstract 307: EphB4 promotes or suppresses Ras/ERK pathway depending on cellular contexts: Implications for EphB4 as a cancer target
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Abstract EphB4 is a member of the Eph RTK family. Its classical role has been shown to act in neuronal guidance and mediate venal/arterial separation. In…”
Get full text
Journal Article